US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 2.149
  • -0.051-2.31%
Trading Apr 26 13:23 ET
547.91MMarket Cap-2310P/E (TTM)

About Lyell Immunopharma Company

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Company Profile

SymbolLYEL
Company NameLyell Immunopharma
Listing DateJun 17, 2021
Issue Price17.00
Founded2018
CEODr. Lynn Seely,M.D.
MarketNASDAQ
Employees224
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address201 Haskins Way
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-695-0677
Websitehttp://www.lyell.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lynn Seely,M.D.
  • Director, President and Chief Executive Officer
  • 2.65M
  • Matthew Lang
  • Chief Business Officer
  • 4.01M
  • Dr. Gary Lee, PhD
  • Chief Scientific Officer
  • 2.23M
  • Stephen Hill
  • Chief Operating Officer
  • 3.11M
  • Charles Newton
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Richard D. Klausner
  • Chairman of the Board
  • 310.75K
  • Hans Edgar Bishop
  • Independent Director
  • 285.75K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 293.25K
  • Robert Taylor Nelsen
  • Independent Director
  • 286.75K
  • Dr. Otis W. Brawley,M.D.
  • Independent Director
  • 290.75K
  • Catherine J. Friedman
  • Lead Independent Director
  • 330.25K
  • William J. Rieflin
  • Independent Director
  • 301.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg